Tag: prostate cancer

What is the link between coffee intake and prostate cancer?

Recent studies debunk the myth, indicating no significant link between coffee intake and prostate cancer development.

The Link Between Coffee Intake and Prostate Cancer: Debunking the Myth

Coffee, one of the most beloved beverages worldwide, has been the subject of numerous studies exploring its effects on our health. Among the concerns raised is the potential link between coffee intake and the development of prostate cancer. In this blog post, we aim to clarify the facts surrounding this topic and debunk any misconceptions.

Over the years, research into the relationship between coffee consumption and prostate cancer has produced varied and often conflicting results. However, recent studies have shed light on this matter, providing a clearer understanding.

A comprehensive review of scientific literature suggests that there is no substantial evidence to support the notion that coffee intake increases the risk of prostate cancer. In fact, some studies have even suggested a potential protective effect of coffee against the development of this type of cancer.

One study, published in the Journal of the National Cancer Institute, analyzed data from nearly 60,000 men and found that coffee consumption was not associated with an increased risk of prostate cancer. Another study conducted by the Harvard School of Public Health reported similar conclusions, stating that moderate coffee consumption does not pose a significant risk factor for prostate cancer.

Moreover, coffee contains bioactive compounds such as antioxidants and polyphenols, which have been shown to possess potential anti-cancer properties. These compounds may help reduce inflammation, protect against DNA damage, and inhibit tumor growth.

It is important to note that while the current body of research suggests no direct link between coffee intake and prostate cancer, individual responses may vary. Factors such as genetic predisposition, lifestyle choices, and overall diet also play crucial roles in cancer development.

As with any aspect of our diet, moderation is key. Enjoying a cup or two of coffee per day can be a part of a balanced and healthy lifestyle, especially when combined with a nutritious diet and regular exercise.

In conclusion, the link between coffee intake and prostate cancer remains inconclusive, with recent studies indicating no significant association. While coffee may not be a direct risk factor for prostate cancer, it is essential to adopt a well-rounded approach to overall health and wellbeing. As always, consulting with healthcare professionals and maintaining a healthy lifestyle are paramount in reducing the risk of any health condition.

Is there any link between buttock pain and prostate cancer?

Yes, there is a link between buttock pain and prostate cancer. Prostate cancer is a type of cancer that develops in the prostate gland, which is a small gland in men that produces semen. In some cases, prostate cancer can spread to the bones, including the bones in the buttocks. This is known as metastatic prostate cancer.

The pain caused by metastatic prostate cancer in the bones can be sharp, dull, or aching. It may be worse at night or with activity. Other symptoms of metastatic prostate cancer in the bones may include:

  • Swelling in the buttocks
  • Numbness or tingling in the buttocks or legs
  • Weakness in the leg
  • Redness or warmth in the buttocks

If you are experiencing buttock pain, it is important to see a doctor to determine the cause. The doctor will likely ask you about your symptoms and medical history. They may also perform a physical exam and order some tests, such as:

  • Blood tests: These tests can help to rule out some underlying medical conditions, such as infection or inflammation.
  • Imaging tests: These tests, such as X-rays, MRIs, or CT scans, can help to look for problems with the bones, muscles, or nerves in the buttocks.

If the doctor suspects that you have metastatic prostate cancer, they may refer you to a specialist, such as an oncologist or a urologist.

It is important to remember that not all cases of buttock pain are caused by prostate cancer. However, if you are experiencing pain that is not going away, it is always best to see a doctor to rule out any serious underlying conditions.

Here are some of the other symptoms of prostate cancer that you should be aware of:

  • Frequent urination, especially at night
  • Weak or interrupted stream of urine
  • Painful urination
  • Blood in the urine or semen
  • erectile dysfunction
  • Pain in the back, hips, or pelvis
  • Unexplained weight loss

If you are experiencing any of these symptoms, it is important to see a doctor right away. Early diagnosis and treatment are essential for the best possible outcome for prostate cancer.

Is there a link between CRP and cancer?

CRP is a biomarker for inflammation in the body. Its elevated level may signal a variety of health issues, such as a bacterial or viral infection. Cancer, including breast, prostate, and colorectal cancer, can cause elevated CRP. The measure is also used to assess cancer patients’ prognosis.

The acute phase protein C-reactive protein (CRP) is produced by the liver during the systemic inflammatory response. Its synthesis is influenced by pro-inflammatory cytokines. CRP is produced into the blood within 24 hours of the inflammatory response beginning and returns to normal when the inflammation decreases.

The CRP standard is < 6 mg/l . Smokers and pregnant women may have higher protein levels.

A high CRP level may indicate:

  • bacterial infections (e.g. streptococcal, staphylococcal infection),
  • viral infections (e.g. hepatitis B),
  • autoimmune inflammatory disease (e.g. lupus, rheumatoid arthritis, enteritis),
  • mycosis.

The C-reactive protein test can also be used to tell the difference between bacterial and viral illnesses. Bacterial infections are more likely to cause significantly increased CRP levels (even greater than 100 mg/l). CRP levels are lower (30-40 mg/l) in viral infections.

CRP and cancer. When is high CRP indicative of cancer?

CRP is a non-specific marker of inflammation, and its elevated level may indicate cancer. Studies report both  1 mg/l and above 175 mg/l, but the higher the score, the greater the likelihood of more advanced cancer, the presence of metastases, and a worse prognosis. 

High CRP is due to the constant, low-grade inflammatory response that accompanies advancing cancer. It is important to remember that not every cancer will result in an elevated C-reactive protein, and not every elevated result will mean that we are dealing with cancer.

What kind of cancer can a high CRP indicate?

Elevated levels of CRP in the blood may indicate various types of cancer, such as:

  • colorectal cancer ,
  • lung cancer ,
  • stomach cancer ,
  • breast cancer
  • prostate cancer (prostate),
  • lymphoma ,
  • pancreatic cancer .

CRP and OB

CRP, like the ESR (Bernacki test), indicates the presence of an inflammatory reaction in the body, although the acute phase protein is a more stable characteristic that does not change as much. CRP has no effect on OB. If the ESR is markedly increased while the CRP is normal, myeloma is most likely present (cancer of the hematopoietic system).

CRP and prognosis in cancer patients

The CRP test is used to determine the prognosis of cancer patients. If the CRP is high and there are no symptoms of infection, the prognosis is poor. That could be an indication of a more serious problem. The CRP test can be used to predict the prognosis of tumors such as lung cancer, colorectal cancer, pancreatic cancer, kidney cancer, and soft tissue sarcoma. However, keep in mind that a high CRP score does not indicate malignancy. Further tests are required to confirm or rule out cancer.

The PSA Test and Prostate Cancer: How Reliable Is It?

The advantages of the blood test for the early detection of prostate cancer have given rise to controversy. Urologists advise against stigmatising the PSA test.

Dr. Schiefelbein warns against devaluing the PSA test, as it is still the most sensitive parameter for early detection of prostate cancer.

The Institute for Quality and Efficiency in Health Care (IQWiG) recommended that statutory health insurance companies not offer or reimburse PSA screening due to the harm it can cause, such as overdiagnosis, overtreatment, and false-positive results.

The American Urological Association demands a PSA test as a health insurance benefit.

The BDU advocates for the approval of the PSA test as a health insurance benefit due to its effectiveness in detecting cancer and minimising the risk of dying from prostate cancer.

The utility value is determined by the individual’s risk profile.

Schiefelbein, a Würzburg urologist, points to the study “European Randomized Study of Screening for Prostate Cancer” (ERSPC) which suggests that the PSA test can reduce mortality from prostate cancer by up to 21 percent and reduce the risk of metastases by up to 42 percent. However, the expert advocates “risk-adapted prostate screening” which takes into account a man’s individual risk profile for prostate cancer, such as an elevated PSA level between the ages of 40 and 45 and if prostate cancer runs in the family. 

For men with a low baseline PSA level at the age of 40 or 45, no family risk and no abnormal physical examination findings, the next check-up may not be necessary for three or five years or more. In men with a family risk, closer monitoring is important.


Prostate cancer: the most common cancer in men

Prostate cancer is the most common type of cancer in men, with 66,900 diagnosed in Germany. Early detection is important, as carcinomas often go undetected for a long time, but are easily curable in the early stages. The examination by the urologist includes rectal palpation of the prostate and genitals, but a tumour that is discovered by palpation is usually more advanced and has a poorer chance of healing.

Dr. Wolfgang Bühmann, urologist and spokesman for the Professional Association of German Urologists (BDU), warns against diagnosing prostate cancer too late. It is possible to have a blood test done in addition to the palpation to determine the PSA value, but the procedure is controversial as it can lead to a short-term increase due to benign prostate enlargement, inflammation, urinary tract infection, or sex and sport. The meaningfulness of the value is not reliable.


What is the PSA value?

PSA is a protein produced by the prostate and released into the semen. It is found in healthy men in small amounts, but increases in prostate cancer.

PSA test as an indicator of prostate disease

PSA levels can be determined by a blood test, which can indicate prostate disease, such as benign hyperplasia or benign inflammation. Prostate carcinoma can also be indicated by an increased PSA value, and further investigations may be initiated.

PSA value in ng/mljudgement
0-2unremarkable, check-up after two years
2-4in need of clarification, control after one year
over 4Tissue sample recommended

How safe is the PSA test?

The PSA test is an important diagnostic method for early detection of prostate cancer, but its result must be viewed in relation to other studies. Healthy men have a PSA level of 0-4 nanograms per milliliter of blood, but if it increases by more than 0.75 nanograms per milliliter of blood each year, a tissue sample is usually taken. This is the only way to determine with certainty whether it is prostate cancer.

“Prostatakrebs: Wie Sicher Der PSA-Test Wirklich Ist.” www.t-online.de, 3 Mar. 2011, www.t-online.de/-/44661722.

Prostate – causes, symptoms, treatment and prevention of prostate diseases

prostate cancer

Men in their mature years are most commonly affected by diseases of the prostate, which is a gland. It can be dangerous to ignore even a mild prostate condition because the bothersome symptoms quickly get worse.

Photo by Anna Tarazevich on Pexels.com

Prostate—what is it?

BPH, or benign prostatic hyperplasia, is the most prevalent prostate condition that impairs male sexual activity. It affects half of all men over the age of 60. It is caused by the growth of glandular cells in the prostate, which put pressure on the urinary tract and make it hard to urinate.

A malignant tumor called PCa, which develops in the prostate much less frequently. Although scientists categorize benign prostatic hyperplasia as a benign tumor because prostate cells can divide indefinitely, the term “benign prostatic hyperplasia” indicates that it is not a malignant cancer.

Prostate: symptoms of prostate diseases

A man in his fifties is likely experiencing the first uncomfortable signs of BPH if he has been getting up at least twice or three times a night to urinate over the past few months. The urge to urinate urgently, even if only a few drops are passed afterward, and urine leakage from the urethra, which necessitates frequent changes of underwear, are other, equally unpleasant prostate symptoms.

Patients with prostate diseases must plan their routes, making several stops at gas stations or public restrooms on the way to work, for example. Men often hold back because they are worried about what will happen to other activities where the penis plays a major role if there are issues with such a minor activity as urinating.

Thankfully, prostate enlargement by itself does not significantly obstruct sexual activity. However, it is important to keep in mind that the seminal fluid, which contains sperm and other substances that allow for proper lubrication and technically facilitate sexual intercourse, is produced in the prostate and seminal vesicles. Although the man’s sexual performance (i.e., his ability to get an erection) is still preserved, any disruption in the production of these compounds may (though it need not) cause discomfort during sexual intercourse.

Prostate: treatment of prostate diseases

Untreated benign hyperplasia causes the urinary tract to completely close off due to prostate compression, which is extremely painful and necessitates catheterization to remove built-up urine. Additionally, as urine returns to the ureters, it puts more pressure on the renal pelvis, eventually causing permanent changes to the kidneys.

Do not wait too long to begin prostate treatment; pharmacotherapy, which is effective in the early and intermediate stages of the disease, should be used as soon as possible. It must be noted, however, that it occasionally occurs that the body becomes accustomed to the medications given, and when they stop working, a prostatectomy—a procedure to remove the prostate—becomes necessary.